In addition, in breast cancer, we identified that MPZL3 is capable of promoting breast cancer cell proliferation and exerts an essential influence on drug therapeutic options, suggesting that MPZL3 serves as a potential prognostic biomarker for breast cancer. The gene discussed is MPZL3; the disease is breast cancer.